nach oben

Journal of Clinical Psychology in Medical Settings

Erschienen in:

20.06.2019 | Acne Inversa

Anger, Emotional Fragility, Self-esteem, and Psychiatric Comorbidity in Patients with Hidradenitis Suppurativa/Acne Inversa

verfasst von: Stefano Tugnoli, Chiara Agnoli, Ambra Silvestri, Silvia Giari, Vincenzo Bettoli, Stefano Caracciolo

Erschienen in: Journal of Clinical Psychology in Medical Settings | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Hidradenitis suppurativa/acne inversa (HS) is one of the most debilitating inflammatory chronic skin diseases and it heavily impairs the emotional and relational life of the patients. Despite its clinical and epidemiological relevance, its psychological correlates are still largely unexplored. The aim of the present study was to investigate the psychological and emotional impact of HS, with a specific focus on psychiatric symptoms, particularly depression, suicidal ideation, self-esteem, anger, and some personality traits. Thirty eight patients diagnosed with HS (HS Group) were compared with a control group of 28 outpatients diagnosed with nevi (N Group) and assessed with psychometric questionnaires (GHQ-28, STAXI-2, BDI-II, BHS, RSES, EF Questionnaire, and I–R Questionnaire). Results showed significant differences between the two groups, with more psychiatric symptoms, lower self-esteem, and higher levels of state anger and of emotional fragility in HS patients. These findings suggest the evidence of a significant psychiatric comorbidity in HS and of a strong emotional impact of the disease.

Alavi, A., Anooshirvani, N., Kim, W. B., Coutts, P., & Sibbald, R. G. (2015). Quality-of-life impairment in patients with hidradenitis suppurativa: A Canadian study. American Journal of Clinical Dermatology, 16, 61–65.PubMed

Alavi, A., Farzanfar, D., Lee, R. K., & Almutairi, D. (2018). The contribution of malodour in quality of life of patients with hidradenitis suppurativa. Journal of Cutaneous Medicine and Surgery, 22, 166–174.PubMed

Alikhan, A., Lynch, P. J., & Eisen, D. B. (2009). Hidradenitis suppurativa: A comprehensive review. Journal of the American Academy of Dermatology, 60, 539–561.PubMed

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (DSM-5). Washington, DC: American Psychiatric Publishing.

Azambuja, R. D. (2017). The need of dermatologists, psychiatrists and psychologists joint care in psychodermatology. Anais Brasileiros de Dermatologia, 92, 63–71.PubMedPubMedCentral

Balieva, F., Kupfer, J., Lien, L., Gieler, U., Finlay, A. Y., Tomás-Aragonés, L., …, & Dalgard, F. J. (2017). The burden of common skin diseases assessed with the EQ5D™: A European multicentre study in 13 countries. British Journal of Dermatology, 176, 1170–1178.

Balieva, F., Lien, L., Kupfer, J., Halvorsen, J. A., & Dalgard, F. (2016). Are common skin diseases among Norwegian dermatological outpatients associated with psychological problems compared with controls? An observational study. Acta Dermato-Venereologica, 96, 227–231.PubMed

Beck, A. T., & Steer, R. A. (1993). Manual for the Beck hopelessness scale (2nd ed.). San Antonio, TX: Psychological Corporation.

Beck, A. T., Steer, R. A., & Brown, G. (1996). BDI-II. Beck depression inventory-II Manual. New York: Psychological Corporation.

Beck, A. T., Weissman, A., Lester, D., & Trexler, L. (1974). The measurement of pessimism: the hopelessness scale. Journal of Consulting and Clinical Psychology, 42, 861–865.PubMed

Benjamins, M., van der Wal, V. B., & de Korte, J. (2009). Quality of life in Dutch patients with hidradenitis suppurativa (acne inversa). Nederlands Tijdschrift voor Dermatologie en Venereologie, 19, 446–450.

Bettoli, V., Pasquinucci, S., Caracciolo, S., Piccolo, D., Cazzaniga, S., Fantini, F., …, & Naldi, L. (2016). The hidradenitis suppurativa patient journey in Italy: Current status, unmet needs and opportunities. Journal of the European Academy of Dermatology and Venereology, 30, 1965–1970.

Bewley, A. P., Fleming, C., & Taylor, R. (2012). Psychocutaneous medicine and its provision in the UK. British Journal of Dermatology, 167, 36–37.

Bridges, K., & Goldberg, D. P. (1986). The validation of the GHQ-28 and the use of the MMSE in neurological in-patients. British Journal of Psychiatry, 148, 548–553.

Caprara, G. V. (1982). A comparison of the frustration-aggression and emotional susceptibility hypotheses. Aggressive Behavior, 8, 234–236.

Caprara, G. V. (1983). La misura dell’aggressività: contributo di ricerca per la costruzione e la validazione di due scale per la misura dell’irritabilità e della suscettibilità emotiva. Giornale Italiano di Psicologia, 10, 91–111.

Caprara, G. V. (1986). Indicators of aggressiveness: The dissipation–rumination scale. Personality and Individual Differences, 7, 763–769.

Caprara, G. V., Barbaranelli, C., Pastorelli, C., & Perugini, M. (1991a). Indicatori della condotta aggressiva: Irritabilità e Ruminazione/Dissipazione—Manuale. Firenze: Organizzazioni Speciali.

Caprara, G. V., Cinanni, V., D’Imperio, G., Passerini, S., Renzi, P., & Travaglia, G. (1985). Indicators of impulsive aggression: Present status of research on irritability and emotional susceptibility scales. Personality and Individual Differences, 6, 665–674.

Caprara, G. V., Perugini, M., Barbaranelli, C., & Pastorelli, C. (1991b). Scala per la misura della fragilità emotiva—Manuale. Firenze: Organizzazioni Speciali.

Caprara, G. V., Renzi, P., Alcini, P., D’Imperio, G., & Travaglia, G. (1983). Instigation to aggress and escalation of aggression examined from a personological perspective: the role of irritability and of emotional susceptibility. Aggressive Behavior, 9, 345–351.

Caprara, G. V., Renzi, P., D’Aguello, D., D’Imperio, G., Rielli, I., & Travaglia, G. (1986). Interpolating physical exercise between instigation to aggress and aggression: The role of irritability and emotional susceptibility. Aggressive Behavior, 12, 83–91.

Comunian, A. L. (2004). STAXI-2—State-trait anger expression inventory. La misura della rabbia. Firenze: OS Organizzazioni Speciali.

Connor, C. J. (2017). Management of the psychological comorbidities of dermatological conditions: practitioners’ guidelines. Clinical, Cosmetic and Investigational Dermatology, 20, 117–132.

Crowley, J. J., Mekkes, J. R., Zouboulis, C. C., Scheinfeld, N., Kimball, A., Sundaram, M., …& Kerdel, F. (2014). Association of hidradenitis suppurativa disease severity with increased risk for systemic comorbidities. British Journal of Dermatology, 171, 1561–1565.

Dalgard, F. J., Gieler, U., Tomas-Aragones, L., Lien, L., Poot, F., Jemec, G. B., …, & Kupfer, J. (2015). The psychological burden of skin diseases: A cross-sectional multicenter study among dermatological out-patients in 13 European countries. Journal of Investigative Dermatology, 135, 984–991.

Danby, F. W., & Margesson, L. J. (2010). Hidradenitis suppurativa. Dermatologic Clinics, 28, 779–793.PubMed

Dauden, E., Lazaro, P., Aguilar, M. D., Blasco, A. J., Suarez, C., Marin, I., … & García Campayo, J. (2018). Recommendations for the management of comorbidity in hidradenitis suppurativa. Journal of the European Academy of Dermatology and Venereology, 32, 129–144.

de Zoysa, P. (2013). Psychological interventions in dermatology. Indian Journal of Dermatology, 58, 56–60.PubMedPubMedCentral

Deckers, I. E., & Kimball, A. B. (2016). The handicap of hidradenitis suppurativa. Dermatologic Clinics, 34, 17–22.PubMed

Delany, E., Gormley, G., Hughes, R., McCarthy, S., Kirthi, S., Markham, T., … & Kirby, B (2018). A cross-sectional epidemiological study of hidradenitis suppurativa in an Irish population (SHIP). Journal of the European Academy of Dermatology and Venereology, 32, 467–473.

Dessinioti, C., Katsambas, A., & Antoniou, C. (2014). Hidradenitis suppurrativa (acne inversa) as a systemic disease. Clinics in Dermatology, 32, 397–408.PubMed

Dufour, D. N., Emtestam, L., & Jemec, G. B. (2014). Hidradenitis suppurativa: a common and burdensome, yet underrecognised, inflammatory skin disease. Postgraduate Medical Journal, 90, 216–221.PubMed

Esmann, S., & Jemec, G. B. (2011). Psychosocial impact of hidradenitis suppurativa: A qualitative study. Acta Dermato-Venereologica, 91, 328–332.PubMed

Finlay-Jones, R. A., & Murphy, E. (1979). Severity of psychiatric disorder and the 30-item GHQ. British Journal of Psychiatry, 134, 609–616.

Garg, A., Pomerantz, H., Midura, M., Papgermanos, V., Strunk, A., Merson, J., & Alloo Hofstra, A. (2017). Completed suicide in patients with hidradenitis suppurativa: A population analysis in the United States. Journal of Investigative Dermatology, 137, S38.

Ghisi, M., Flebus, G. B., Montano, A., Sanavio, E., & Sica, C. (2006). Beck Depression Inventory-II. Manuale italiano. Firenze: Organizzazioni Speciali.

Goldberg, D. P. (1972). The detection of psychiatric illness by questionnaire. Maudsley Monograph No 21. London: Oxford University Press.

Goldberg, D. P. (1978). Manual of the General Health Questionnaire. Windsor: NFER Publishing.

Goldberg, D. P., Gater, R., Sartorius, N., Ustun, T. B., Piccinelli, M., Gureje, O., & Rutter, C. (1997). The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychological Medicine, 27, 191–197.PubMed

Goldberg, D. P., & Hillier, V. F. (1979). A scaled version of the General Health Questionnaire. Psychological Medicine, 9, 139–145.PubMed

Gooderham, M., & Papp, K. (2015). The psychosocial impact of hidradenitis suppurativa. Journal of the American Academy of Dermatology, 73, S19–S22.PubMed

Gupta, M. A., & Gupta, A. K. (1996). Psychodermatology: An update. Journal of the American Academy of Dermatology, 34, 1030–1036.PubMed

Gupta, M. A., & Levenson, J. L. (2017). Dermatological Disorders. In J. L. Levenson & S. J. Ferrando (Eds.), Clinical manual of psychopharmacology in the medically ill (pp. 515–554). Arlington, VA: American Psychiatric Association Publishing.

Heatherton, T. F., & Wyland, C. L. (2003). Assessing self-esteem. In S. J. Lopez & C. R. Snyder (Eds.), Positive psychological assessment: A handbook of models and measures (pp. 219–233). Washington, DC: American Psychological Association.

Horváth, B., Janse, I. C., & Sibbald, G. R. (2015). Pain management in patients with hidradenitis suppurativa. Journal of the American Academy of Dermatology, 73, S47–S51.PubMed

Hughes, J. E., Barraclough, B. M., Hamblin, L. G., & White, J. E. (1983). Psychiatric symptoms in dermatology patients. British Journal of Psychiatry, 143, 51–54.

Huilaja, L., Tiri, H., Jokelainen, J., Timonen, M., & Tasanen, K. (2018). Patients with hidradenitis suppurativa have a high psychiatric disease burden: A Finnish nationwide registry study. Journal of Investigative Dermatology, 138, 46–51.PubMed

Jackson, C. (2007). The General Health Questionnaire. Occupational Medicine, 57, 79.

Jafferany, M., & Pastolero, P. (2018). Psychiatric and psychological impact of chronic skin disease. The Primary Care Companion for CNS Disorders. https://doi.org/10.4088/PCC.17nr02247.CrossRefPubMed

Janse, I. C., Deckers, I. E., van der Maten, A. D., Evers, A. W. M., Boer, J., van der Zee, H. H., … & Horváth, B. (2017). Sexual health and quality of life are impaired in hidradenitis suppurativa: A multicentre crosssectional study. British Journal of Dermatology, 176, 1042–1047.

Jemec, G. B. (2017). Quality of life considerations and pain management in hidradenitis suppurativa. Seminars in Cutaneous Medicine and Surgery, 36, 75–78.PubMed

Jemec, G. B. (2018). Hidradenitis suppurativa and intimacy. International Journal of Women’s Dermatology, 5, 72–73.

Jemec, G. B., Heidenheim, M., & Nielsen, N. H. (1996). The prevalence of hidradenitis suppurativa and its potential precursor lesions. Journal of the American Academy of Dermatology, 35, 1914.

Kaaz, K., Matusiak, L., & Szepietowski, J. C. (2017). Sleep disturbances among hidradenitis suppurativa patients. Experimental Dermatology, 26, 3–38.

Kennedy, J. (2008). Hidradenitis suppurativa: A diagnostic dilemma for sexual health. New Zealand Medical Journal, 121, 58–62.PubMed

Kirby, J. S., Butt, M., Esmann, S., & Jemec, G. B. E. (2017). Association of resilience with depression and healthrelated quality of life for patients with hidradenitis suppurativa. JAMA Dermatology, 153, 1263–1269.PubMedPubMedCentral

Kjaersgaard Andersen, R., Theut Riis, P., & Jemec, G. B. E. (2018). Factors predicting the self-evaluated health of hidradenitis suppurativa patients recruited from an outpatient clinic. Journal of the European Academy of Dermatology and Venereology, 32, 313–317.PubMed

Kluger, N., Ranta, M., & Serlachius, M. (2017). The burden of hidradenitis suppurativa in a cohort of patients in Southern Finland: A pilot study. Skin Appendage Disord, 3, 20–27.PubMedPubMedCentral

Kontochristopoulos, G., Sygros, A., Kouris, A., Tzanetakou, V., Platsidaki, E., Christodoulou, C., Dessinioti, C. & Antoniou, C. (2017). Quality of life and psychosocial implications in hidradenitis suppurativa. Journal of the American Academy of Dermatology, 76.

Kouris, A., Platsidaki, E., Christodoulou, C., Efstathiou, V., Dessinioti, C., Tzanetakou, V., …, & Kontochristopoulos, G. (2016). Quality of life and psychosocial implications in patients with hidradenitis suppurativa. Dermatology, 232, 687–691.

Kurek, A., Johanne Peters, E. M., Sabat, R., Sterry, W., & SchneiderBurrus, S. (2013). Depression is a frequent comorbidity in patients with acne inversa. Journal der Deutschen Dermatologischen Gesellschaft, 11, 743–749.PubMed

Kurek, A., Peters, E. M., Chanwangpong, A., Sabat, R., Sterry, W., & Schneider-Burrus, S. (2012). Profound disturbances of sexual health in patients with acne inversa. Journal of the American Academy of Dermatology, 67, 422–428.PubMed

Maikhanh Nguyen, C., Danesh, M., Beroukhim, K., Sorenson, E., Leon, A., & Koo, J. (2015). Psychodermatology: A Review. Practical Dermatology, 5, 49–54.

Matusiak, L. (2018). Profound consequences of hidradenitis suppurativa: A review. British Journal of Dermatology. https://doi.org/10.1111/bjd.16603.CrossRefPubMed

Matusiak, L., Bieniek, A., & Szepietowski, J. C. (2010a). Hidradenitis suppurativa markedly decreases quality of life and professional activity. Journal of the American Academy of Dermatology, 62, 706–708.PubMed

Matusiak, L., Bieniek, A., & Szepietowski, J. C. (2010b). Psychophysical aspects of hidradenitis suppurativa. Acta Dermato-Venereologica, 90, 264–268.PubMed

Matusiak, L., Szczęch, J., Kaaz, K., Lelonek, E., & Szepietowski, J. C. (2018). Clinical characteristics of pruritus and pain in patients with hidradenitis suppurativa. Acta Dermato-Venereologica, 98, 191–194.PubMed

Miller, I. M., McAndrew, R. J., & Hamzavi, I. (2016). Prevalence, risk factors, and comorbidities of hidradenitis suppurativa. Dermatologic Clinics, 34, 7–16.PubMed

Nazary, M., Van der Zee, H. H., Prens, E. P., Folkerts, G., & Boer, J. (2011). Pathogenesis and pharmacotherapy of hidradenitis suppurativa. European Journal of Pharmacology, 672, 1–8.PubMed

Ofenloch, R. F. (2017). Healthrelated quality of life in hidradenitis suppurativa. British Journal of Dermatology, 176, 861–862.PubMed

Onderdijk, A. J., Van der Zee, H. H., Esmann, S., Lophaven, S., Dufour, D. N., Jemec, G. B., & Boer, J. (2013). Depression in patients with hidradenitis suppurativa. Journal of the European Academy of Dermatology and Venereology, 27, 473–478.PubMed

Papadopoulos, L., Bor, R., & Legg, C. (1999). Psychological factors in cutaneous disease: An overview of research. Psychology, Health & Medicine, 4, 107–126.

Patel, Z. S., Hoffman, L. K., Buse, D. C., Grinberg, A. S., Afifi, L., Cohen, S. R., …, & Seng, E.K. (2017). Pain, psychological comorbidities, disability, and impaired qualify of life in hidradenitis suppurativa. Current Pain and Headache Report, 21, 49.

Picardi, A., Abeni, D., Melchi, C. F., Puddu, P., & Pasquini, P. (2000). Psychiatric morbidity in dermatological outpatients: an issue to be recognized. British Journal of Dermatology, 143, 983–991.PubMed

Pompili, M., Iliceto, P., Lester, D., Innamorati, M., Girardi, P., & Tatarelli, R. (2009). BHS Beck Hopelessness Scale. Manuale. Firenze: Giunti O.S. Organizzazioni Speciali.

Poot, F., Sampogna, F., & Onnis, L. (2007). Basic knowledge in psychodermatology. Journal of the European Academy of Dermatology and Venereology, 21, 227–234.PubMed

Porter, M. L., & Kimball, A. B. (2017). Comorbidities of hidradenitis suppurativa. Seminars in Cutaneous Medicine and Surgery, 36, 55–57.PubMed

Prezza, M., Trombaccia, F. R., & Armento, L. (1997). La scala dell’autostima di Rosenberg: traduzione e validazione italiana. Bollettino di Psicologia Applicata, 223, 35–44.

Rabins, P. V., & Brooks, B. R. (1981). Emotional disturbance in multiple sclerosis patients: Validity of the General Health Questionnaire (GHQ). Psychological Medicine, 11, 425–427.PubMed

Ramussen, J. E. (1990). Psychosomatic dermatology. Archives of Dermatology, 126, 90–93.

Rodriquez-Vallecio, E., & Woodbury-Farina, M. A. (2014). Dermatological manifestation of stress in normal and psychiatric population. Psychiatric Clinics of North America, 37, 625–651.

Romas, J. A., & Sharma, M. (2017). Managing anger and resolving conflicts. In J. A. Romas & M. Sharma (Eds.), Practical stress management (pp. 91–109). Cambridge: Academic Press.

Root, S., Kent, G., & Al’Abadie, M. S. K. (1994). Disease severity, disability and stress in patients undergoing PUVA treatment for psoriasis. Dermatology, 189, 234–237.PubMed

Rosenberg, M. (1965). Society and the adolescent self-image. Princeton, NJ: Princeton University Press.

Sajatovic, M., & Ramirez, L. F. (2003). Rating scales in mental health (2nd ed.). Hudson, OH: Lexi-Comp.

Sampogna, F., Abeni, D., Gieler, U., Tomas-Aragones, L., Lien, L., Titeca, G., …, & Dalgard, F. (2017). Impairment of sexual life in 3485 dermatological outpatients from a multicentre study in 13 European countries. Acta Dermato-Venereol, 97, 478–482.

Sartorius, K., Emtestam, L., Jemec, G. B., & Lapins, J. (2009). Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity. British Journal of Dermatology, 161, 831–839.PubMed

Sartorius, K., Killasli, H., Heilborn, J., Jemec, G. B., Lapins, J., & Emtestam, L. (2010). Interobserver variability of clinical scores in hidradenitis suppurativa is low. British Journal of Dermatology, 162, 1261–1268.PubMed

Sartorius, K., Lapins, J., Emtestam, L., & Jemec, G. B. (2003). Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa. British Journal of Dermatology, 149, 211–213.PubMed

Saunte, D. M., Boer, J., Stratigos, A., Szepietowski, J. C., Hamzavi, I., Kim, K. H., …, & Jemec, G. B. (2015). Diagnostic delay in hidradenitis suppurativa is a global problem. British Journal of Dermatoloy, 173, 1546–1549.

Saunte, D. M. L., & Jemec, G. B. E. (2017). Hidradenitis suppurativa: Advances in diagnosis and treatment. JAMA, 318, 2019–2032.PubMed

SchneiderBurrus, S., Jost, A., Peters, E. M. J., WitteHaendel, E., Sterry, W., & Sabat, R. (2018). Association of hidradenitis suppurativa with body image. JAMA Dermatology, 154, 447–451.

Shah, R. B. (2018). Impact of collaboration between psychologists and dermatologists: UK hospital system example. International Journal of Women’s Dermatology, 4, 8–11.PubMed

Shavit, E., Dreiher, J., Freud, T., Halevy, S., Vinker, S., & Cohen, A. D. (2015). Psychiatric comorbidities in 3207 patients with hidradenitis suppurativa. Journal of the European Academy of Dermatology and Venereology, 29, 371–376.PubMed

Shenefelt, P. D. (2010). Psychological interventions in the management of common skin conditions. Psychology Research and Behavior Management, 3, 51–63.PubMedPubMedCentral

Shlyankevich, J., Chen, A. J., Kim, G. E., & Kimball, A. B. (2014). Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: A chartverified casecontrol analysis. Journal of the American Academy of Dermatology, 71, 1144–1150.PubMed

Slyper, M., Strunk, A., & Garg, A. (2018). Incidence of sexual dysfunction among patients with hidradenitis suppurativa: A population based retrospective analysis. British Journal of Dermatology, 179, 502–503.PubMed

Smith, H. S., Chao, J. D., & Teitelbaum, J. (2010). Painful hidradenitis suppurativa. Clinical Journal of Pain, 26, 435–444.PubMed

Spielberger, C. D. (1999). State-trait anger expression inventory-2: Professional manual. Odessa, FL: Psychological Assessment Resources Inc.

Thompson, C. (Ed.). (1989). The instruments of psychiatric research. Chichester: Wiley-Blackwell.

Thorlacius, L., Cohen, A. D., Gislason, G. H., Jemec, G. B. E., & Egeberg, A. (2018). Increased suicide risk in patients with hidradenitis suppurativa. Journal of Investigative Dermatology, 138, 52–57.PubMed

Tiri, H., Jokelainen, J., Timonen, M., Tasanen, K., & Huilaja, L. (2018). Somatic and psychiatric comorbidities of hidradenitis suppurativa in children and adolescents. Journal of the American Academy of Dermatology, 79, 514–519.PubMed

Tugnoli, S., Bettoli, V., Agnoli, C., & Caracciolo, S. (2016a). Emotions and bodily experience in hidradenitis suppurative-acne inversa. Clinica Terapeutica, 167, 55–62.

Tugnoli, S., Bettoli, V., Agnoli, C., Giari, S., Toni, G., Virgili, A., & Caracciolo, S. (2016b). Psychiatric morbidity and anger in patients with hidradenitis suppurativa-acne inversa and the impact on quality of life of caregivers. Experimental Dermatology, 25, 13.

Tugnoli, S., Bettoli, V., Agnoli, C., Giari, S., Virgili, A., & Caracciolo, S. (2015). Correlati psicoaffettivi in pazienti con idrosadenite suppurativa-acne inversa. Medicina Psicosomatica, 60, 44.

Tugnoli, S., Silvestri, A., Agnoli, C., Giari, S., Caracciolo, S., & Bettoli, V. (2017). Psychiatric comorbidity, depression, self-esteem and anger in patients with hidradenitis suppurativa-acne inversa. Experimental Dermatology, 26, 31.

van Hemert, A. M., den Heijer, M., Vorstenbosch, M., & Bolk, J. H. (1995). Detecting psychiatric disorders in medical practice using the General Health Questionnaire. Why do cut-off scores vary? Psychological Medicine, 25, 165–170.PubMed

Vangipuram, R., Vaidya, T., Jandarov, R., & Alikhan, A. (2016). Factors contributing to depression and chronic pain in patients with hidradenitis suppurativa: Results from a single-center retrospective review. Dermatology, 232, 692–695.PubMed

Vazquez, B. G., Alikhan, A., Weaver, A. L., Wetter, D. A., & Davis, M. D. (2013). Incidence of hidradenitis suppurativa and associated factors: A population-based study of Olmsted County, Minnesota. Journal of Investigative Dermatology, 133, 97–103.PubMed

Vekic, D. A., & Cains, G. D. (2018). Hidradenitis suppurativa, a review of pathogenesis, associations and management. Part 2. Australasian Journal of Dermatology, 59, 261–266.PubMed

von der Werth, J. M., & Jemec, G. B. (2001). Morbidity in patients with hidradenitis suppurativa. British Journal of Dermatology, 144, 809–813.PubMed

Vossen, A. R. J. V., Schoenmakers, A., van Straalen, K. R., Prens, E. P., & van der Zee, H. H. (2017). Assessing pruritus in hidradenitis suppurativa: A cross-sectional study. American Journal of Clinical Dermatology, 18, 687–695.PubMedPubMedCentral

Wolkenstein, P., Loundou, A., Barrau, K., Auquier, P., & Revuz, J. (2007). Quality of life Group of the French Society of Dermatology. Quality of life impairment in hidradenitis suppurativa: A study of 61 cases. Journal of the American Academy of Dermatology, 56, 621–623.PubMed

Wood, J. M., & Gupta, S. (2017). Using rating scales in a clinical setting: A guide for psychiatrists. Current Psychiatry, 16, 21–25.

Yadav, S., Narang, T., & Kumaran, M. S. (2013). Psychodermatology: A comprehensive review. Indian Journal of Dermatology, Venereology and Leprology, 79, 176–192.PubMed

Yazdanyar, S., & Jemec, G. B. (2011). Hidradenitis suppurativa: A review of cause and treatment. Current Opinion in Infectious Diseases, 24, 118–123.PubMed

Zouboulis, C. C., Desai, N., Emtestam, L., Hunger, R. E., Ioannides, D., Juhász, I., …, & Jemec, G. B. (2015). European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. Journal of the European Academy of Dermatology and Venereology, 29, 619–644.

Titel: Anger, Emotional Fragility, Self-esteem, and Psychiatric Comorbidity in Patients with Hidradenitis Suppurativa/Acne Inversa
verfasst von: Stefano Tugnoli
Chiara Agnoli
Ambra Silvestri
Silvia Giari
Vincenzo Bettoli
Stefano Caracciolo
Publikationsdatum: 20.06.2019
Verlag: Springer US
Schlagwort: Acne Inversa
Erschienen in: Journal of Clinical Psychology in Medical Settings / Ausgabe 3/2020
Print ISSN: 1068-9583
Elektronische ISSN: 1573-3572
DOI: https://doi.org/10.1007/s10880-019-09640-4

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2020

Adverse Childhood Experiences and Chronic Medical Conditions: Emotion Dysregulation as a Mediator of Adjustment

The Impact of a Gluten-Free Diet on Celiac Disease: A Comprehensive Evaluation of Two Cases Using NIH Patient Reported Outcome Measures (PROMIS, NTCB, and Neuro-QoL)

The Moderating Role of Maternal Supervision in the Relation of Social–Ecological Risk Factors to Children’s Minor Injuries

Integrating Behavioral Healthcare and Primary Care, Appropriate Balance on What Model is Driving Care, and, the Whole Spectrum of Individuals are Coming Through the Door…

Initial Validation of IBD KNOW-IT: Measuring Patient and Caregiver Knowledge of a Child’s Disease and Treatment Regimen

Social Problem Solving and Posttraumatic Growth New Possibilities in Postoperative Breast Cancer Survivors